Re: JMP conference transcript
|
4
|
Mannkind
|
Jul 11, 2013 05:31PM
|
Re: New medicine
|
1
|
Mannkind
|
Jul 11, 2013 08:53AM
|
Re: Best Defensive Strategy
|
4
|
Mannkind
|
Jul 09, 2013 04:44PM
|
Re: A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
2
|
Mannkind
|
Jul 08, 2013 05:10PM
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 11:36AM
|
Equity Profile Report Initiates Watch On MNKD
|
1
|
Mannkind
|
Jul 02, 2013 10:43AM
|
Re: MannKind announces $160M debt financing
|
2
|
Mannkind
|
Jul 01, 2013 05:05PM
|
Re: MannKind announces $160M debt financing
|
4
|
Mannkind
|
Jul 01, 2013 09:45AM
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
|
Mannkind
|
Jun 28, 2013 09:56AM
|
Re: Question Regarding ATM
|
1
|
Mannkind
|
Jun 28, 2013 08:54AM
|
Re: New SA Article
|
1
|
Mannkind
|
Jun 27, 2013 12:14PM
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 09:58AM
|
New SA Article
|
|
Mannkind
|
Jun 27, 2013 08:59AM
|
New Article About Approvals
|
1
|
Mannkind
|
Jun 26, 2013 01:28PM
|
Re: New from Novo..
|
4
|
Mannkind
|
Jun 24, 2013 11:40AM
|
New Diabetes Eating Study
|
2
|
Mannkind
|
Jun 24, 2013 09:48AM
|
Re: Trades At The Close Out Of Control
|
|
Mannkind
|
Jun 21, 2013 11:07PM
|
Trades At The Close Out Of Control
|
1
|
Mannkind
|
Jun 21, 2013 04:03PM
|
Re: Biotech Stock Mailbag: .MannKind
|
4
|
Mannkind
|
Jun 21, 2013 08:25AM
|
Re: From the Yahoo board
|
|
Mannkind
|
Jun 20, 2013 12:28PM
|